Samira Mubareka

Samira completed her MD at Dalhousie University and Internal Medicine training at McGill University in Canada. She specialized in Infectious Diseases and Medical Microbiology at the University of Manitoba and went on to a research fellowship at the Mount Sinai School of Medicine, New York City.

Samira is currently a virologist, medical microbiologist and infectious disease physician at Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada and in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Samira has been working on SARS-CoV-2 since the outset of the pandemic in North America with a focus on virus biology, bioaerosols, genomics and wildlife surveillance through close and cross-disciplinary collaborations. She is currently focused on understanding the biology and transmission of SARS-CoV-2 variants of concern and on coronavirus and influenza virus zoonotic spillover.

Samira served on the Chief Science Advisor of Canada, Dr. M. Nemer’s COVID-19 Expert Panel, the Implementation Committee of the Genome Canada-led Canadian COVID-19 Genomics Network (CanCOGeN) VirusSeq project, ISED’s Therapeutics Task Force, and the Ontario COVID-19 Science Advisory Table. She Chaired the Royal Society of Canada’s COVID-19 One Health Working Group and currently serves on the Royal Society of Canada’s One Health Task Force.